JP2021523877A5 - - Google Patents

Info

Publication number
JP2021523877A5
JP2021523877A5 JP2020544255A JP2020544255A JP2021523877A5 JP 2021523877 A5 JP2021523877 A5 JP 2021523877A5 JP 2020544255 A JP2020544255 A JP 2020544255A JP 2020544255 A JP2020544255 A JP 2020544255A JP 2021523877 A5 JP2021523877 A5 JP 2021523877A5
Authority
JP
Japan
Prior art keywords
day
glp1r agonist
phenyl
agonist
glp1r
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020544255A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021523877A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/030110 external-priority patent/WO2019217165A1/en
Publication of JP2021523877A publication Critical patent/JP2021523877A/ja
Publication of JP2021523877A5 publication Critical patent/JP2021523877A5/ja
Priority to JP2024081189A priority Critical patent/JP2024112903A/ja
Pending legal-status Critical Current

Links

JP2020544255A 2018-05-08 2019-05-01 Ｇｌｐ１ｒアゴニストの治療的使用 Pending JP2021523877A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024081189A JP2024112903A (ja) 2018-05-08 2024-05-17 Ｇｌｐ１ｒアゴニストの治療的使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862668384P 2018-05-08 2018-05-08
US62/668,384 2018-05-08
PCT/US2019/030110 WO2019217165A1 (en) 2018-05-08 2019-05-01 Therapeutic uses of glp1r agonists

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024081189A Division JP2024112903A (ja) 2018-05-08 2024-05-17 Ｇｌｐ１ｒアゴニストの治療的使用

Publications (2)

Publication Number Publication Date
JP2021523877A JP2021523877A (ja) 2021-09-09
JP2021523877A5 true JP2021523877A5 (https=) 2022-05-17

Family

ID=66484210

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020544255A Pending JP2021523877A (ja) 2018-05-08 2019-05-01 Ｇｌｐ１ｒアゴニストの治療的使用
JP2024081189A Pending JP2024112903A (ja) 2018-05-08 2024-05-17 Ｇｌｐ１ｒアゴニストの治療的使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024081189A Pending JP2024112903A (ja) 2018-05-08 2024-05-17 Ｇｌｐ１ｒアゴニストの治療的使用

Country Status (9)

Country Link
US (2) US20210023072A1 (https=)
EP (1) EP3790549A1 (https=)
JP (2) JP2021523877A (https=)
KR (2) KR20260036616A (https=)
AU (2) AU2019266114A1 (https=)
CA (1) CA3090823A1 (https=)
MX (1) MX2020008387A (https=)
SG (1) SG11202007966UA (https=)
WO (1) WO2019217165A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4048664A1 (en) 2019-10-25 2022-08-31 Gilead Sciences, Inc. Glp-1r modulating compounds
ES3016132T3 (en) 2020-01-29 2025-05-08 Gilead Sciences Inc Glp-1r modulating compounds
US12459954B2 (en) 2020-04-01 2025-11-04 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Crystalline form a of GLP-1 receptor agonist and preparation method therefor
JP2023528726A (ja) * 2020-04-01 2023-07-06 ハンジョウ ジョンメイ フアドン ファーマシューティカル シーオー．，エルティーディー． Ｇｌｐ１ｒアゴニスト遊離塩基の薬学的に許容される酸塩類およびその調製法
CN115667222B (zh) * 2020-05-28 2023-09-29 杭州中美华东制药有限公司 一种制备glp-1受体激动剂的方法
EP4213847A4 (en) * 2020-09-21 2024-12-04 vTv Therapeutics LLC AMORPHOUS FORM OF AN ISOQUINOLINE DERIVATIVE
EP4247804A1 (en) 2020-11-20 2023-09-27 Gilead Sciences, Inc. Polyheterocyclic glp-1 r modulating compounds
WO2022192428A1 (en) 2021-03-11 2022-09-15 Gilead Sciences, Inc. Glp-1r modulating compounds
EP4304712A1 (en) 2021-03-11 2024-01-17 Gilead Sciences, Inc. Glp-1r modulating compounds
IL306110A (en) 2021-04-21 2023-11-01 Gilead Sciences Inc Carboxy-benzimidazole glp-1r modulating compounds
KR102920994B1 (ko) 2024-05-20 2026-02-02 (주)인벤티지랩 오르포르글리포론 또는 이의 약학적으로 허용되는 염을 포함하는 마이크로 입자 및 이의 제조 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000042026A1 (en) * 1999-01-15 2000-07-20 Novo Nordisk A/S Non-peptide glp-1 agonists
EA018225B1 (ru) 2008-03-07 2013-06-28 Транстек Фарма, Инк. Соединения оксадиазоантрацена для лечения диабета
CN102378574B (zh) 2009-03-30 2013-11-20 转化技术制药公司 取代的偶氮蒽衍生物、药物组合物及其使用方法
US20110064806A1 (en) * 2009-09-11 2011-03-17 Transtech Pharma, Inc. Solid compositions comprising an oxadiazoanthracene compound and methods of making and using the same
EA201491749A1 (ru) * 2012-03-22 2015-01-30 ТРАНСТЕК ФАРМА, ЭлЭлСи Трис-(гидроксиметил)аминометановые соли низкомолекулярного агониста glp1r, их фармацевтические композиции и применение
AU2014207748B2 (en) * 2013-01-17 2018-10-11 Vtv Therapeutics Llc Combinations of a GLP1R agonist and metformin and use thereof for the treatment of type 2 diabetes and other disorders

Similar Documents

Publication Publication Date Title
JP2021523877A5 (https=)
US20250325536A1 (en) Therapeutic uses of glp1r agonists
CN101511364B (zh) 用于糖尿病的治疗组合
JP6066144B2 (ja) 併用医薬
US20110269750A1 (en) Roflumilast for the treatment of diabetes mellitus
JP2015044875A5 (https=)
JP2016518438A5 (https=)
JP2024515137A (ja) Ｇｐｒ４０アゴニスト及びｓｇｌｔ－２阻害剤を含む医薬組成物
TWI519297B (zh) 使用雙醋瑞因之糖尿病輔助療法
KR20260027165A (ko) 의료 요법에서의 세마글루티드
CN116157132A (zh) 一种降低血糖的组合、应用和方法
US9241956B2 (en) Pharmaceutical preparation and method for treatment of diabetes
TWI918593B (zh) Glp1r激動劑的治療用途
WO2006094942A1 (en) Roflumilast for the treatment of diabetes mellitus
RU2021130019A (ru) Состав низкодозовой тройной комбинации
JP2011105609A (ja) メトホルミンへの付加療法を含む２型糖尿病の治療方法